Outcomes in Patients with Cancer-Associated Venous Thromboembolism Receiving Immune Checkpoint Inhibitors: A Matched Cohort Study

被引：0
|
作者：
Danielian, Pedro Luiz Lage Bodour [1 ]
Dave, Heloni M. [2 ]
Wei, Wei [3 ]
Patel, Mehrie H. [1 ]
Angelini, Dana Elizabeth [1 ]
Khorana, Alok A. [1 ]
机构：
[1] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH USA
[2] Cleveland Clin, Akron, OH USA
[3] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-211304
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5578 / 5579
页数：2
相关论文
共 50 条
  • [1] Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study
    Kopolovic, Ilana
    Lee, Agnes Y. Y.
    Wu, Cynthia
    ANNALS OF HEMATOLOGY, 2015, 94 (02) : 329 - 336
  • [2] Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study
    Ilana Kopolovic
    Agnes Y. Y. Lee
    Cynthia Wu
    Annals of Hematology, 2015, 94 : 329 - 336
  • [3] Immune Checkpoint Inhibitors for Cancer Are Associated With Increased Venous Thromboembolism Events
    Gong, Jingyi
    Drobni, Zsofia
    Alvi, Raza
    Murphy, Sean
    Hartmann, Sarah
    Gilman, Hannah
    Zubiri, Leyre
    Raghu, Vineet
    Sullivan, Ryan
    Zafar, Amna
    Zlotoff, Daniel A.
    Frigault, Matthew
    Karp-Leaf, Rebecca
    Reynolds, Kerry
    Neilan, Tomas G.
    CIRCULATION, 2020, 142
  • [4] Immune checkpoint inhibitors: risk of venous thromboembolism in cancer patients examined
    Reactions Weekly, 2023, 1960 (1) : 12 - 12
  • [5] Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitors
    Kartolo, Adi
    Yeung, Cynthia
    Moffat, Gordon T.
    Hanna, Lilian
    Hopman, Wilma
    Baetz, Tara
    IMMUNOTHERAPY, 2022, 14 (01) : 23 - 30
  • [6] Validation of risk assessment scores in predicting venous thromboembolism in patients with lung cancer receiving immune checkpoint inhibitors
    Zhang, Jiarui
    Xie, Yufang
    Yang, Linhui
    Yang, Mengzhu
    Xu, Rui
    Liu, Dan
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [7] Incidence, Characteristics and Outcomes of Patients with Cancer-Associated Venous Thromboembolism: A Retrospective Matched-Pair Analysis
    Kongtim, Piyanuch
    Charoenjit, Dhosaporn
    Saengboon, Supawee
    Ratanabunjerdkul, Hataiwan
    BLOOD, 2018, 132
  • [8] Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study
    Alessandro Squizzato
    Silvia Galliazzo
    Elena Rancan
    Marina Di Pilla
    Giorgia Micucci
    Gianmarco Podda
    Emanuele Valeriani
    Leonardo Campiotti
    Lorenza Bertù
    Walter Ageno
    Ettore Porreca
    Corrado Lodigiani
    Internal and Emergency Medicine, 2022, 17 : 83 - 90
  • [9] Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study
    Squizzato, Alessandro
    Galliazzo, Silvia
    Rancan, Elena
    Di Pilla, Marina
    Micucci, Giorgia
    Podda, Gianmarco
    Valeriani, Emanuele
    Campiotti, Leonardo
    Bertu, Lorenza
    Ageno, Walter
    Porreca, Ettore
    Lodigiani, Corrado
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (01) : 83 - 90
  • [10] Risk of Venous Thromboembolism in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors
    Attia, Doaa
    Wei, Wei
    Pennell, Nathan A.
    McCrae, Keith R.
    Khorana, Alok A.
    Patil, Pradnya
    BLOOD, 2021, 138
12345